TED Ted Baker Plc

RNS Number:8146X
Tepnel Life Sciences PLC
27 June 2002


PRESS RELEASE

For Further Information:

Tepnel Life Sciences                                            0161 946 2200
Ben Matzilevich, CEO
Gron Ffoulkes-Davies, Finance Director

HCC De Facto Group                                              020 7496 3300
David Dible / Mark Swallow


Tepnel Life Sciences ('Tepnel') Signs T1000 Distribution Agreement with
Biotech Line AS For Denmark

Manchester, UK. 27 June 2002...Tepnel Life Sciences PLC (AIM: TED) is pleased to
announce today that it has signed a distribution agreement for its T1000
Automated DNA Purification System. The agreement with Danish company Biotech
Line AS covers the marketing in Denmark of the T1000, associated consumables and
Tepnel's NucleonTM manual DNA purification products and future systems for the
purification of genomic DNA.

Under the terms of this multiple year distribution agreement, Biotech Line, a
specialist distributor of biomedical instruments and reagents, will immediately
purchase a number of T1000 systems and has committed to on-going purchases for
additional instruments.

The T1000, which was launched in December 2001, is Tepnel's first automated
system for plasmid DNA purification. This cost-effective, dedicated system,
which is specifically designed for academic laboratories and research
laboratories within pharmaceutical and biotechnology industries combines
ease-of-use with complete automation and excellent performance, and generates
high-quality DNA suitable for automated DNA sequencing systems.

"We are very pleased to have signed this agreement for the T1000 and associated
products with Biotech Line, which is one of the Denmark's key distributors of
instruments and reagents," said Ben Matzilevich, Tepnel's CEO. "This agreement
marks another step forward for Tepnel in terms of getting its products into the
important biomedical research markets around the world, and we are optimistic of
announcing more partners for the T1000 during the rest of the year."



                                     -ends-



Notes to Editors

Tepnel Life Sciences is a global biotechnology company with a "tripolar"
strategy focused on providing the biomedical industry with high-throughput
automated DNA purification systems, manual DNA purification kits and reagents,
as well as scientific services for nucleic acid purification, drug analysis,
genotyping and genetically modified foods (GMOs).

The Company was founded in 1992 to exploit DNA technology generated at UMIST
(University of Manchester Institute of Science and Technology) and is listed on
the AIM segment of the London Stock Exchange (AIM: TED).


www.tepnel.com



                      This information is provided by RNS
            The company news service from the London Stock Exchange

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024